Durable remissions are rare following high dose therapy with autologous stem cell transplantation for adults with "paediatric" bone and soft tissue sarcomas

BACKGROUND: The role of high dose therapy (HDT) with autologous stem cell transplantation (AuSCT) for the treatment of bone and soft tissue sarcomas remains investigational. There are few reports examining this strategy focusing on the adult population. METHODS: We retrospectively reviewed our exper...

Descripción completa

Detalles Bibliográficos
Autores principales: Nath, Shriram V, Prince, H Miles, Choong, Peter FM, Toner, Guy C
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1164428/
https://www.ncbi.nlm.nih.gov/pubmed/15927067
http://dx.doi.org/10.1186/1477-7800-2-12

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1164428/
https://www.ncbi.nlm.nih.gov/pubmed/15927067
http://dx.doi.org/10.1186/1477-7800-2-12

Ejemplares similares